GLS and rheumatoid arthritis: Hence, the current study was undertaken to identify a set of novel yet highly potent phytobiological inhibitor leads from Dracaena trifasciata against the underlying metabolic reprogramming in RA by targeting HK2 and GLS1 via computer aided drug designing (CADD) (Figure S1).